Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer Journal Article
| Author: | Dang, C. |
| Article Title: | Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer |
| Keywords: | treatment outcome; treatment response; overall survival; clinical trial; fluorouracil; cancer combination chemotherapy; drug efficacy; treatment duration; note; paclitaxel; adjuvant therapy; disease free survival; lymph node metastasis; multiple cycle treatment; breast cancer; tumor volume; clinical assessment; epidermal growth factor receptor 2; cyclophosphamide; high risk patient; fluorescence in situ hybridization; add on therapy; diagnostic value; early cancer; epirubicin; taxane derivative; diagnostic test; estrogen receptor; progesterone receptor; anthracycline; hormone receptor; menopause |
| Journal Title: | Current Breast Cancer Reports |
| Volume: | 1 |
| Issue: | 1 |
| ISSN: | 1943-4588 |
| Publisher: | Springer |
| Date Published: | 2009-03-01 |
| Start Page: | 1 |
| End Page: | 2 |
| Language: | English |
| DOI: | 10.1007/s12609-009-0001-9 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 30 November 2010" - "Source: Scopus" |
